[1] CHEN M，SALLBERG M，HUGHES J，et al. Immune tolerance split between hepatitis B virus precore and core proteins[J]. J Virol，2005，79（5）：3016-3027.
[2] BRECHOT C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma:old and new paradigms[J]. Gastroenterology，2004，127（suppl1）：S56-S61.
[3] BAUMERT TF，YANG C，SCHURMANN P，et al. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes[J]. Hepatology，2005，41（2）：247-256.
[4] VON WEIZSACKER F，KOCK J，MACNELLY S，et al. The tupaia model for the study of hepatitis B virus:direct infection and HBV genome transduction of primary tupaia hepatocytes[J]. Methods Mol Med，2004，96:153-161.
[5] CHISARI FV，PINKERT CA，MILICH DR，et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J]. Science，1985，230（4730）：1157-1160.
[6] ARAKI K，MIYAZAKI J，HINO O，et al. Expression and replication of hepatitis B virus genome in transgenic mice[J]. Proc Natl Acad Sci U S A，1989，86（1）：207-211.
[7] KIM CM，KOIKE K，SAITO I，et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice[J]. Nature，1991，351（6324）：317-320.
[8] GUIDOTTI LG，ROCHFORD R，CHUNG J，et al. Viral clearance without destruction of infected cells during acute HBV infection[J]. Science，1999，284（5415）：825-829.
[9] LARKIN J，CLAYTONM，SUN B，et al. Hepatitis B virus transgenic mouse model of chronic liver disease[J]. Nat Med，1999，5（8）：907-912.
[10] CHISARI FV，FILIPPI P，BURAS J，et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice[J]. Proc Natl Acad Sci U S A，1987，84（19）：6909-6913.
[11] BOUCHARD MJ，SCHNEIDER RJ. The enigmatic X gene of hepatitis B virus[J]. J Virol，2004，78（23）：12725-12734.
[12] HALVERSCHEID L，MANNES NK，WETH R，et al. Transgenic mice replicating hepatitis B virus but lacking expression of the major HBsAg[J]. J Med Virol，2008，80（4）：583-90.
[13] ILAN E，BURAKOVA T，DAGAN S，et al. The hepatitis B virus trimera mouse:a model for human HBV infection and evaluation of anti-HBV therapeutic agents[J]. Hepatology，1999，29（2）：553-562.
[14] OHASHI K，MARION PL，NAKAI H，et al. Sustained survival of human hepatocytes in mice:a model for in vivo infection with human hepatitis B and hepatitis delta viruses[J]. Nat Med，2000，6（3）：327-331.
[15] BROWN JJ，PARASHAR B，MOSHAGE H，et al. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice[J]. Hepatology，2000，31 （1）：173-181.
[16] DANDRI M，BURDA MR，TOROK E，et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus[J]. Hepatology，2001，33（4）：981-988.
[17] MEULEMAN P，LIBBRECHT L，DE VOS R，et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera[J]. Hepatology，2005，41（4）：847-856.
[18] TATENO C，YOSHIZANE Y，SAITO N，et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs[J]. Am J Pathol，2004，165（3）：901-912.
[19] TSUGE M，HIRAGA N，TAKAISHI H，et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus[J]. Hepatology，2005，42（5）：1046-1054.
[20] DANDRI M，BURDA MR，ZUCKERMAN DM，et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes[J]. J Hepatol，2005，42 （1）：54-60.
[21] SPRINZL MF，OBERWINKLER H，SCHALLER H，et al. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier[J]. J Virol，2001，75（11）：5108-5118.
[22] YANG PL， ALTHAGE A，CHUNG J，et al. Hydrodynamic injection of viral DNA:a mouse model of acute hepatitis B virus infection[J]. Proc Natl Acad Sci U S A，2002，99（21）：13825-13830.
[23] HUANG LR，WU HL，CHEN PJ，et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J]. Proc Natl Acad Sci U S A，2006，103（47）：17862-17867.
[24] YING RS，ZHU C，FAN XG，et al. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice[J]. Antiviral Res，2007，73 （1）：24-30. |
